Fredun Pharmaceuticals Allots Equity Shares Following Warrant Conversion
Fredun Pharmaceuticals Limited announced the allotment of 106,668 equity shares to a promoter following the conversion of warrants. The decision was made at a board meeting held on March 25, 2026.Previously, convertible warrants were allotted to the promoter on a preferential basis on December 29, 2025, as approved by shareholders in an Extraordinary General Meeting held on October 22, 2025. The warrant holders have paid a total of Rs. 10,00,01,250 and exercised their right to convert the warrants into equity shares.
The allotment comprises 106,668 equity shares with a face value of Rs. 10 each. The details of the allotment are as follows:
| Sr. No. | Name of Allottee | Category of Investor | Total number of convertible warrants allotted on December 29, 2025 | Number of Equity Shares allotted on March 25, 2026 | Number of Warrants Outstanding for Conversion |
|---|---|---|---|---|---|
| 1 | Mr. Fredun Nariman Medhora | Promoter | 1,60,000 | 1,06,668 | 53,332 |
| TOTAL | 1,60,000 | 1,06,668 | 53,332 |
The allotted equity shares will be in dematerialized form and rank pari passu with existing equity shares.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.